biochem - lipid metabolism Flashcards
functions of lipids
- energy source
- components of cell membrane (phospholipids)
- communication molecules (steroid hormones)
why do FAs have even number of carbons
- when synthesized, 2 Cs are added at once by organisms
essential fatty acids in the body
- omega-3 FA (double bond is on 3rd C atom, where C1 is the non-carboxylic end of FA)
- omega-6 FA
problem with trans fatty acids
- increase LDL, decreases HDL→ atherosclerosis
dietary lipids composition
10%
- cholesterol, cholesterol esters, phospholipids, fatty acids
90%
- TAG (triacylglycerol, aka TG triglyceride)
enzymes for digestion of different lipid forms
TAG
- digested by lipase (mouth, stomach, pancreas)
- TAG→ diacylglycerol→ 2-monoacylglycerol + 2FA
cholesterol ester
- digested by cholesterol esterase (pancreatic)
- cholesterol ester→ cholesterol + FA
phospholipid
- digested by phospholipase A2 (pancreatic)
- phospholipid→ lysophospholipid/lysolecithin + FA
lipid digestion based on location
Stomach
- lingual lipase (mouth) and gastric lipase (stomach): digest triglycerides in the stomach
- lingual lipase is more active in the stomach as it requires low pH
Small intestine
- major site of lipid digestion
- secretion of bile salts and pancreatic lipase/colipase
- emulsification of fats by bile salts to form micelles
- digestion of fats mediated by enzymes (e.g pancreatic lipase, cholesterol esterase and phospholipase A2)
- absorption into enterocytes
function of colipase
- bind to pancreatic lipase & anchors it to micelle
- remove inhibitory effect of bile salts on pancreatic lipase
- essentially increases activity of pancreatic lipase
hormones released by small intestine for lipid digestion (2)
cholecystokinin (CCK)
- released by intestinal cells (when stomach content enters intestine)
- stimulate bile salt + pancreatic lipase/colipase secretion
secretin
- released by intestinal cells
- stimulate HCO3- release from pancreas→ neutralise acidic chyme from stomach→ provides optimal pH for pancreatic digestive enzymes to work
orlistat function & points to note when consuming
- inhibit release of gastric & pancreatic lipase -> decrease fat absorption
- take daily supplement of vit A,D,E,K (fat soluble, impaired absorption when lipids are not absorbed into body)
reasons for steatorrhea (excessive fat in feces) & complications
impaired lipid digestion
- bile salt deficiency
- pancreatic insufficiency
- disease in small intestine -> affect lipid absorption
complications:
- impaired absorption of vit A,D,E,K
what happens to lipids after absorption into small intestine (3)
- reforming of initial lipids
- monoacylglycerol + 2FAs→ TAG
- cholesterol + FA → CHOLESTEROL ESTER
- lysophospholipid + FA→ PHOSPHOLIPID - formation of nascent chylomicron
- TAG, cholesterol esters, phospholipid + fat soluble vitamins→ form nascent chylomicron
- ApoB-48 (produced by ENTEROCYTES) required for proper assembly of chylomicron - export into lymphatic system
- chylomicron transport out of enterocyte to lymphatics via EXOCYTOSIS
what is the structure of lipoproteins eg chylomicrons?
outer layer
- single layer phospholipid: phosphate group face out; hydrophobic FA chains face inward
- embedded apolipoproteins: essential in structure, metabolism & function of lipoprotein particles
core (lipids)
- TAG, cholesterol esters
where and how do nascent chylomicrons get converted to mature chylomicrons
- movement from lymph nodes (nascent) into blood (mature)
- HDLs in blood transfer apolipoproteins ApoE and ApoCII to nascent chylomicrons→ mature
what are the apoproteins on mature vs nascent chylomicrons?
nascent: ApoB48
mature: ApoCII, ApoE, ApoB48
why do nascent chylomicrons enter lymphatics (and not directly into blood)
- too large to fit through blood vessel (lymphatics have larger gaps between endothelial cells)
- moves to blood circulation at subclavian vein (not impt)
function of mature chylomicrons
converted to energy stores (adipose tissue) or metabolised (muscle):
- ApoCII (LPL co-factor) on mature CM→ activate LIPOPROTEINLIPASE (LPL) on capillary endothelium NEAR MUSCLE tissue/ ADIPOSE tissue→ breakdown of chylomicron core
- LPL converts TAG→ FAs + glycerol
- FA is used to generate ATP in muscle + converted to TG for storage in adipose tissue
uptake by liver for lipogenesis
- glycerol from breakdown of TAG by LPL taken up by liver
- chylomicron remnants contains ApoE -> interact with liver receptor -> uptake via ENDOCYTOSIS -> lysosome in liver fuse with endocytic chylomicron vessels -> degrade chylomicron remnants to from FA, aa, cholesterol, glycerol -> nutrients are taken up by hepatocytes
what are chylomicron remnants
- mature chylomicrons are broken down by LPL -> process cause loss of ApoCII & change in conformation
- chylomicron remnants no longer have ApoCII, but still contain B48 and ApoE apolipoproteins
hyperchylomicronemia pathogenesis
- genetic, deficiency in LPL/ ApoCII -> impair hydrolysis of TAG in mature chylomicrons
- severe hypertriglyceridemia
- xanthoma (lipid buildup under skin) on arms, buttocks, knees due to formation of foam cells in skin (macrophage engulfing lipids)
*patients advised to maintain low fat diet
de novo lipogenesis
- endogenous synthesis of fatty acid from non lipid precursor (usually glucose)
rate limiting step in de novo lipogenesis
- conversion of acetyl CoA to malonyl CoA (catalysed by acetyl CoA carboxylase)
allosteric regulation of ACC (acetyl CoA carboxylase)
- upregulated by citrate
- inhibited by long chain fatty acyl CoA (-ve feedback)
hormonal regulation of ACC
- upregulated by insulin
- inactivated by glucagon and epinephrine
where is fatty acid synthase found
- cytoplasm, converts malonyl CoA & acetyl CoA to fatty acid
what is fatty acid synthase expression induced by
- insulin (signals presence of glucose for fat synthesis)
how is TAG (components: FA, glycerol) synthesized in liver
FAs
- de novo lipogenesis from glucose
glycerol
- direct glycerol uptake (from chylomicron remnants)
- derive from DHAP (from glucose)
how is TAG synthesized in adipose tissue
FAs
- uptake (dietary and hepatic)
glycerol
- derive from DHAP
formation of VLDL process
- lipoprotein synthesized in liver -> secreted from liver as NASCENT VLDL (containing ApoB100)
- in blood, nascent VLDL acquire ApoE, ApoCII (from HDL) -> forms MATURE VLDL
contents of VLDL
- contains TAG -> FAs are predominantly sythesized by DE NOVO LIPOGENESIS
function of VLDL
- deliver hepatic TAG to other tissue (similar MOA as chylomicrons -> VLDL taken up by muscles & adipose tissue through LPL interaction with ApoCII -> remaining glycerol is taken up by liver)
what happens to VLDL after losing TAG at LPL
- VLDL loses TAG -> becomes smaller sized (intermediate density lipoprotein, IDL)
- IDL reuptake by liver can occur through interaction with ApoE receptor on IDL
- IDL can also stay in blood circulation for longer -> lose more TAG -> becomes LDL
steatosis (fatty liver) types (2)
accumulation of TAG in vacuoles of hepatocytes
- excessive alcohol intake -> alcoholic fatty liver disease (AFLD)
- metabolic syndrome (eg obesity, diabetes, htn) -> non alcoholic fatty liver disease (NAFLD)
pathogenesis of steatosis in hepatocytes
- increase in FA synthesis by hepatocytes -> cause increase in TAG synthesis
- rate of TAG synthesis > VLDL synthesis -> accumulation of TAG in liver
- impaired VLDL secretion